by editor | Aug 19, 2014 | Blog, Pharmaceutical, StockGuru
Skinvisible is taking all of the necessary steps forward to make Kintari a success. Let me say this first – all of Skinvisible Pharmaceutical’s core business continues. They have an incredible patent portfolio and many products that have already make it to...
by Featured | Aug 19, 2014 | Blog, Breaking News, Medical Stocks, Pharmaceutical
Important Pharmaceutical Updates:Rich Pharmaceuticals (OTCQB: RCHA) moves to OTCQB.Skinvisible Pharmaceuticals (OTCBB: SKVI) Announces additional details on its Networking Marketing subsidiary, Kintari. First – RCHA:Rich Pharmaceuticals, Inc. (OTCQB: RCHA) is...
by Featured | Aug 14, 2014 | Blog, Breaking News, Featured, Medical Stocks, Pharmaceutical, Top
Skinvisible and Kintari Expands Team of ExpertsKey Direct Sales and Production Staff AddedSkinvisible Pharmaceuticals, Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari, is pleased to announce the addition of Rob Barnes as Director of Sales. Rob will...
by Featured | Aug 7, 2014 | Blog, Breaking News, Featured, Medical Stocks, Pharmaceutical, Top
Skinvisible Announces Expansion With a New Scientific Skincare Company”Premium Invisicare Powered Kintari(TM) Products Go to Market”Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) today announced the forming of Kintari, a new wholly-owned subsidiary to...
by editor | Feb 11, 2013 | Blog, Pharmaceutical, StockGuru, StockGuru Blog
Dear Members,Number One: The Market Cap is Far Too Low for What This Company Already Has BecomeSkinvisible Pharmaceuticals (SKVI) is not a quick pick for us. It is a Company we know well, and we are happy to share with our membership. While we did discuss over the...
by editor | Feb 10, 2013 | Blog, Medical Stocks, Pharmaceutical
Dear Members, First – Let’s Look at Netherton Syndrome I am not going to show you pictures of Netherton Syndrome. That’s not because you should not see how horrible this affliction is, but I do not want to violate the privacy of any patient (mostly...